Researchers associated with Mindbloom just published an article arguing that at-home ketamine-assisted therapy is not only safe but led to improvements (<50%) in depression and anxiety in 62% of participants.
Despite psychedelics remaining highly controlled – it hasn’t deterred investors and a sizeable market has developed.
We examine what is happening in the psychedelic landscape and make this accessible in short daily articles. Some articles put the news into context, others excerpt our long-form reports to make a key insight visible. At other times, the bits serve as a place to share an interview, viewpoint, or experience. All to keep you in the loop on what’s happening in psychedelics as medicine.